Advances in the Treatment of Myasthenia Gravis

Increasing knowledge about the underlying pathophysiology of myasthenia gravis is accelerating treatment development. These discoveries are being translated into meaningful improvement in the quality of life for patients afflicted with this disease. Not only are new medications within existing classifications and new medication combinations emerging, but whole new classes of medications are being developed at an exponentially advancing rate. This course presents a description of the disease, diagnosis, and various treatments. The material includes historical, current, and experimental interventions for control, or possible cure for this debilitating disease.

State Boards of Nursing have varying positions on the role of the LPN/LVN in the administration of infusion therapy, including the administration of antineoplastic agents. A link to each state board of nursing is listed here. Competency requirements are obtained and maintained through the nurse’s employer, facility, or institution.